The role of EphA2 in cancer is controversial as opposite outcomes, linked to malignant transformation and progression, are induced by the ligand-dependent signaling (i.e., canonical pathway) respect to the ligand-independent signaling (i.e., non-canonical pathway) [103]. The gene discussed is EPHA2; the disease is cancer.